Oxford BioMedica PLC (LON:OXB)
633p-0.16%
Spriggl Score: Weak— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Turnaround confirmed with first-ever profit and bold £500M 2030 target; distressed balance sheet keeps this firmly high-risk.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Oxford BioMedica PLC
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £726.1M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Oxford BioMedica PLC and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free